CARMELL THERAPEUTICS
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repai... red tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).
CARMELL THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical Device Therapeutics
Founded:
2007-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.carmellrx.com
Total Employee:
1+
Status:
Active
Contact:
4122088033
Total Funding:
9.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Board_member
Board_member
Board_member
2011-01-01
Board_member
2016-02-01
Current Employees Featured
James Hart Chief Medical Officer @ Carmell Therapeutics
Chief Medical Officer
Stephanie Kladakis Chief Scientific Officer @ Carmell Therapeutics
Chief Scientific Officer
Phil Campbell Founder @ Carmell Therapeutics
Founder
Donna Godward Chief Quality Officer @ Carmell Therapeutics
Chief Quality Officer
James Burgess Founder @ Carmell Therapeutics
Founder
2008-07-01
Lee Weiss Founder @ Carmell Therapeutics
Founder
Sebby Borriello Chief Business Officer @ Carmell Therapeutics
Chief Business Officer
2022-05-01
Founder
Investors List
Innovation Works
Innovation Works investment in Seed Round - Carmell Therapeutics
Jay Yue
Jay Yue investment in Convertible Note - Carmell Therapeutics
Maine Angels
Maine Angels investment in Series B - Carmell Therapeutics
Keiretsu Forum
Keiretsu Forum investment in Series B - Carmell Therapeutics
Harbor Light Capital Partners
Harbor Light Capital Partners investment in Series B - Carmell Therapeutics
BlueTree Allied Angels
BlueTree Allied Angels investment in Series B - Carmell Therapeutics
Newlin Investment Company
Newlin Investment Company investment in Series B - Carmell Therapeutics
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Series B - Carmell Therapeutics
Lehigh Valley Angel Investors
Lehigh Valley Angel Investors investment in Angel Round - Carmell Therapeutics
Innovation Works
Innovation Works investment in Debt Financing - Carmell Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-11 | Carmell Therapeutics Announces the Appointment of Sebastian “Sebby” Borriello to Chief Business Officer |
Official Site Inspections
http://www.carmellrx.com
- Host name: cwi1.pairnic.net
- IP address: 216.92.3.51
- Location: Pittsburgh United States
- Latitude: 40.4236
- Longitude: -79.9825
- Metro Code: 508
- Timezone: America/New_York
- Postal: 15203
More informations about "Carmell Therapeutics"
Carmell Cosmetics - Crunchbase Company Profile
Carmell Therapeutics completed the acquisition of Elevai Skincare, which expanded its portfolio in the skincare industry. The company entered into a …See details»
Carmell Therapeutics - Overview, News & Similar companies
Explore Complete Organization Structure. Is Carmell Therapeutics your ideal customer? Let us give you the heads up on whether it's a good time to reach out. ... Carmell Therapeutics …See details»
Alpha Healthcare Acquisition Corp. III Announces …
Jan 5, 2023 Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft ...See details»
Carmell Cosmetics | LinkedIn
Carmell Cosmetics | 1,790 followers on LinkedIn. Bio-aesthetics for skin & hair | The world's most advanced regenerative skincare based on up to 1000+ biological proteins, …See details»
Carmell Therapeutics Company Profile | Management and
Smith@carmellrx.com: Carmell Therapeutics Top Competitors. Company Employees Revenue Top technologies; Isofol Medical. n/a: $2.1 M: Topas Therapeutics. n/a: $5.9 M: OZ …See details»
Carmell Corporation Announces Completion of Post …
PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the completion of post-merger integration with ...See details»
Carmell Therapeutics Announces Merger with Axolotl Biologix, a ...
Jul 27, 2023 For more information, visit www.carmellrx.com. Forward-Looking Statements This press release contains forward-looking statements that are based on beliefs and assumptions …See details»
Carmell Cosmetics
This three piece Face and Neck collection brings the full Carmell Secretome™ line to your skincare routine. This kit contains: Regenerative Elixir: The Carmell Secretome™ flagship, our Regenerative Elixir is a clinically tested, silicone …See details»
Cantilever Investors | Carmell Therapeutics
Biotechnology. Carmell is a biotechnology company focused on the development and commercialization of regenerative medicine technologies. Founded as a spin-out of Carnegie …See details»
Carmell CEO and Key Executive Team | Craft.co
Carmell's Chairman & CEO is Rajiv Shukla. Other executives include James Hart, Chief Medical Officer; Donna Godward, Chief Quality Officer and 3 others. See the full leadership team at Craft.See details»
Why Pittsburgh biotech company Carmell Therapeutics is going …
Sep 12, 2022 Why is Carmell Therapeutics, poised to become the newest public company in the Pittsburgh region, taking that big step? CEO Randy Hubbell said it's the right move for the …See details»
Carmell Therapeutics - Owler
Carmell Therapeutics’s Profile, Revenue and Employees. Carmell Therapeutics is a Pennsylvania-based bio-aesthetics company that develops plasma-driven proteins and …See details»
Carmell Therapeutics Corporation Company Profile & Introduction …
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors …See details»
Organization: Carmell Therapeutics - Cbonds.com
Carmell Therapeutics Corporation is a regenerative medicine biotech company. The Company focuses on developing plasma-based bioactive material to stimulate tissue repair after injury, …See details»
Carmell Therapeutics Announces the Appointment of Sebastian …
May 11, 2022 Randy Hubbell rhubbell@carmellrx.com (412) 894-1875 Release Summary Sebastian "Sebby" Borriello joins Carmell Therapeutics bringing 30+ years of pharmaceutical, …See details»
Carmell Corporation Announces Completion of Post-Merger
Sep 5, 2023 For more information, visit www.carmellrx.com Forward-Looking Statements This press release contains forward-looking statements that are based on beliefs and assumptions …See details»
Carmell Therapeutics | Life Sciences PA
Carmell Therapeutics (Carmell™) is a regenerative medicine biotech company focused on leveraging our core platform technology, Plasma-based Bioactive Material (“PBM”). PBM is a …See details»
Carmell Therapeutics Announces Confidential Submission of Draft ...
Sep 7, 2022 Sebby Borriello sborriello@carmellrx.com (215) 801-0882 Release Summary Carmell Therapeutics announces draft registration statement on Form S-1 with the SEC …See details»
Carmell Therapeutics Merges With Axolotl Biologix | citybiz
Jul 28, 2023 PITTSBURGH & FLAGSTAFF, Ariz.–(BUSINESS WIRE)–Carmell Therapeutics Corporation, a regenerative medicine company today announced the execution of a definitive …See details»
Carmell Corporation Announces Completion of Post-Merger …
Sep 5, 2023 For more information, visit www.carmellrx.com Forward-Looking Statements This press release contains forward-looking statements that are based on beliefs and assumptions …See details»